Mr. R., 64, arrives with an anterior STEMI and is already in shock: systolic pressure in the 80s on norepinephrine, lactate rising, ejection fraction about 25% on echo. He is awake and following commands. He is on the cath-lab table and the culprit artery has not yet been opened. The team is choosing his support, and someone mentions a pump trial that found no benefit. The shock course follows him from the cath lab to the ICU; each trial answers one decision in his care.
This page helps you decide: An earlier pump trial found no benefit. Why does it not settle the question for Mr. R.?
After this page you can
Work through the six steps in order. Each question at the end belongs to one step, and the answer is on that step's page.
For Mr. R., IMPRESS settles nothing: in 48 ventilated patients 30-day death was 46% vs 50%, with a hazard-ratio interval from 0.42 to 2.18, wide enough for a large benefit or real harm, and Mr. R. is awake and not ventilated, so he would not have been enrolled. A small trial with no significant difference has not answered the question; his answer comes from DanGer Shock. On the one-pager it sits on page 2, in the “Temporary mechanical support in AMI shock — what the randomized trials show” table, microaxial flow pump row.